Grace Therapeutics (GRCE) EPS (Basic) (2019 - 2026)
Grace Therapeutics (GRCE) posted EPS (Basic) of -$0.07 for Q1 2026, up 47.81% sequentially from -$0.14 in Q4 2025, and down 830.85% YoY from $0.01 in Q1 2025.
Grace Therapeutics (GRCE) EPS (Basic) (2019 - 2026) Analysis & Trends
Grace Therapeutics has reported EPS (Basic) for 8 years, with the latest figure at -$0.07 in Q1 2026.
- Quarterly EPS (Basic) fell 830.85% year-over-year to -$0.07 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.47 (up 43.43% YoY) and the FY2026 annual result came in at -$0.47, up 43.43% from the prior year.
- EPS (Basic) advanced to -$0.07 in Q1 2026 per GRCE's latest filing, from -$0.14 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.01 in Q1 2025 and troughed at -$5.2 in Q1 2023.
- A 5-year average of -$0.61 and a median of -$0.3 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2023 and 2025: EPS (Basic) sank 1694.16% in 2023, then surged 102.0% in 2025.
- Over 5 years, EPS (Basic) stood at -$0.52 in 2022, then surged by 60.27% to -$0.21 in 2023, then plunged by 73.78% to -$0.36 in 2024, then jumped by 62.14% to -$0.14 in 2025, then surged by 47.81% to -$0.07 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.07, -$0.14, and -$0.06 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 0.18 |
| 10 | Grace Therapeutics | 37.82 Mn | 37.82 Mn | - | -0.91 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.91 |
| Mar 31, 2026 | -0.07 |
| Dec 31, 2025 | -0.14 |
| Sep 30, 2025 | -0.06 |
| Jun 30, 2025 | -0.21 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | -0.36 |
| Sep 30, 2024 | -0.30 |
| Jun 30, 2024 | -0.24 |
| Mar 31, 2024 | -0.49 |
| Dec 31, 2023 | -0.21 |
| Sep 30, 2023 | -0.43 |
| Jun 30, 2023 | -0.54 |
| Mar 31, 2023 | -5.20 |
| Dec 31, 2022 | -0.52 |
| Sep 30, 2022 | -0.66 |
| Jun 30, 2022 | -0.61 |
| Mar 31, 2022 | -0.29 |
| Dec 31, 2021 | -0.51 |
| Sep 30, 2021 | 0.18 |